LMR Partners’s Boston Scientific BSX Stock Holding History

LMR Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-275,000	Closed	-$17.3M	–	1529
2026 Q1	$17.3M	Buy	275,000 +107,900	+65%	+$8.63M	0.04%	245
2025 Q4	$15.9M	Hold	167,100	–	–	0.03%	243
2025 Q3	$16.3M	Buy	167,100 +162,900	+3,879%	+$16.9M	0.07%	211
2025 Q2	$451K	Buy	+4,200	New	+$425K	﹤0.01%	974
2025 Q1	–	Sell	-500	Closed	-$44.7K	–	1391
2024 Q4	$44.7K	Sell	500 -38,500	-99%	-$3.39M	﹤0.01%	1044
2024 Q3	$3.27M	Buy	39,000 +10,700	+38%	+$843K	0.03%	468
2024 Q2	$2.18M	Hold	28,300	–	–	0.02%	529
2024 Q1	$1.94M	Hold	28,300	–	–	0.02%	554
2023 Q4	$1.64M	Buy	+28,300	New	+$1.51M	0.02%	505

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LMR Partners's BSX Position: Q2 2026 in Review

LMR Partners reduced its Boston Scientific (BSX) stake by 54% in Q2 2026, selling an estimated $6.81M and leaving 107,478 shares worth $4.59M. The position accounts for 0.02% of the portfolio, ranked #686.

LMR Partners first reported a position in BSX in Q2 2014 and has held it in 34 quarters since. The position peaked at $14.6M in Q1 2026. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

LMR Partners held 107,478 shares of Boston Scientific worth $4.59M as of Q2 2026.
LMR Partners sold 125,323 Boston Scientific shares in Q2 2026, an estimated $6.81M.
Boston Scientific made up 0.02% of LMR Partners's portfolio in Q2 2026, its #686 holding.
LMR Partners first reported a position in Boston Scientific in Q2 2014 and has held it in 34 quarters since.
LMR Partners's Boston Scientific position peaked at $14.6M in Q1 2026.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.